Skip to search formSkip to main contentSkip to account menu

FIGO Stage III

A FIGO stage term that applies to gynecologic cancers. For cervical cancer, it refers to cancer that extends to the pelvic wall, and/or involves the… 
National Institutes of Health

Related topics

Related topics

5 relations
FIGO Stage III Ovarian CancerFIGO Stage IIIA1 Ovarian CancerFIGO Stage IIIA2 Ovarian CancerStage IIIA Ovarian Carcinoma

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Staging for vulvar cancer.
Review
2014
Review
2014
Impact of management on the prognosis of pure uterine papillary serous cancer - a Taiwanese Gynecologic Oncology Group (TGOG) study.
2013
2013
Long-term results and prognostic factors in patients with stage III–IVA squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy from a single institution study
BackgroundWe evaluated the longer-term efficacy and safety of concurrent chemoradiotherapy (CCRT) incorporating high-dose-rate… 
2012
2012
Over-Expression of Semaphorin4D, Hypoxia-Inducible Factor-1α and Vascular Endothelial Growth Factor Is Related to Poor Prognosis in Ovarian Epithelial Cancer
Semaphorin4D (SEMA4D) has been regarded as an important protein in tumor angiogenesis, though originally identified in… 
2009
2009
Tspan-1 is a tetraspanin preferentially expressed by mucinous and endometrioid subtypes of human ovarian carcinomas.
2007
2007
The activated nerve growth factor receptor p-TrkA is selectively expressed in advanced-stage ovarian carcinoma.
Highly Cited
2003
Highly Cited
2003
Consolidation treatment of advanced (FIGO stage III) ovarian carcinoma in complete surgical remission after induction chemotherapy: A randomized, controlled, clinical trial comparing whole abdominal…
  • B. Sorbe
  • International Journal of Gynecologic Cancer
  • 2003
  • Corpus ID: 34029883
In a prospective randomized trial, consolidation treatment with radiotherapy or chemotherapy was compared with no treatment in a… 
Highly Cited
2003
Highly Cited
2003
Multivariate analysis for prognostic significance of histologic subtype, GST‐pi, MDR‐1, and p53 in stages II‐IV ovarian cancer
It has been suggested that histologic subtype of ovarian cancer is a factor that determines the chemoresponsiveness of tumor. In… 
1999
1999
p53 Protein expression in squamous cell carcinoma of the vulva
The objective of the study was to evaluate the pathogenetic and prognostic value of p53 protein expression in squamous cell… 
Highly Cited
1997
Highly Cited
1997
EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patients.
Epidermal growth factor receptor (EGFR), progesterone receptor (PR) and estrogen receptor (ER) status were analyzed in 108… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)